Long-term follow-up for patients using preimplantation genetic testing
Follow-up With Preimplantation Genetic Testing Patients
This study is trying to learn about the long-term experiences and outcomes of people who have used preimplantation genetic testing during IVF to help improve care in reproductive genetics.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Sex | All |
| Sponsor | Genomic Prediction Inc. Industry-sponsored |
| Locations | 1 site (North Brunswick, New Jersey) |
| Trial ID | NCT04477863 on ClinicalTrials.gov |
What this trial studies
This observational study aims to conduct longitudinal evaluations of clinical outcomes and personal perspectives of patients who have undergone preimplantation genetic testing (PGT) as part of in vitro fertilization (IVF). Eligible participants will be those who consented to research during their PGT informed consent process. A licensed genetic counselor will conduct recorded interviews to gather data on their experiences and outcomes. The study seeks to recruit a total of 10,000 patients to provide valuable insights for improving clinical care in the field of reproductive genetics.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have undergone preimplantation genetic testing and indicated a willingness to participate in research during the informed consent process.
Not a fit: Patients who opted out of participating in research during their PGT informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of patient experiences and outcomes related to preimplantation genetic testing, potentially leading to improved IVF practices.
How similar studies have performed: While there have been studies on PGT, this longitudinal approach focusing on personal perspectives and outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients indicating willingness to participate in research during informed consent to perform PGT Exclusion Criteria: * Patients who opted out of participating in research during informed consent to perform PGT
Where this trial is running
North Brunswick, New Jersey
- Genomic Prediction Clinical Laboratory — North Brunswick, New Jersey, United States (Recruiting)
Study contacts
- Principal investigator: Nathan R Treff, PhD — Genomic Prediction
- Study coordinator: Talia Metzgar, RN
- Email: Talia@genomicprediction.com
- Phone: (973) 529-4223
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.